JP Morgan Chase’s Teladoc Health TDOC Stock Holding History

JP Morgan Chase’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,400	Closed	-$213K	–	7721
2024 Q4	$213K	Buy	23,400 +19,800	+550%	+$191K	﹤0.01%	5448
2024 Q3	$33K	Hold	3,600	–	–	﹤0.01%	6120
2024 Q2	$35.2K	Buy	+3,600	New	+$43.9K	﹤0.01%	5986
2023 Q2	–	Sell	-90,100	Closed	-$2.33M	–	7321
2023 Q1	$2.33M	Buy	+90,100	New	+$2.41M	﹤0.01%	3436
2022 Q1	–	Sell	-38,801	Closed	-$3.56M	–	7009
2021 Q4	$3.56M	Hold	38,801	–	–	﹤0.01%	3339
2021 Q3	$4.92M	Sell	38,801 -1,500	-4%	-$218K	﹤0.01%	3036
2021 Q2	$6.7M	Buy	40,301 +1,500	+4%	+$243K	﹤0.01%	2792
2021 Q1	$7.05M	Sell	38,801 -218,950	-85%	-$50.8M	﹤0.01%	2674
2020 Q4	$51.5M	Buy	+257,751	New	+$52.4M	0.01%	1053
2020 Q2	–	Sell	-27,000	Closed	-$4.18M	–	5694
2020 Q1	$4.18M	Hold	27,000	–	–	﹤0.01%	2415
2019 Q4	$2.26M	Buy	+27,000	New	+$2.05M	﹤0.01%	3302
2019 Q1	–	Sell	-1,000	Closed	-$50K	–	6039
2018 Q4	$50K	Buy	+1,000	New	+$61.2K	﹤0.01%	5079

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's TDOC Position: Q1 2026 in Review

JP Morgan Chase reduced its Teladoc Health (TDOC) stake by 13% in Q1 2026, selling an estimated $437K and leaving 539,927 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3848.

JP Morgan Chase first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $489M in Q1 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

JP Morgan Chase held 539,927 shares of Teladoc Health worth $2.78M as of Q1 2026.
JP Morgan Chase sold 77,858 Teladoc Health shares in Q1 2026, an estimated $437K.
Teladoc Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3848 holding.
JP Morgan Chase first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
JP Morgan Chase's Teladoc Health position peaked at $489M in Q1 2020.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.